期刊文献+

接种甲肝疫苗建立群体免疫屏障的效益分析 被引量:2

Cost-benefit Analysis of Building the Colony lmmune Defence by a Mass Vaccination of Hepatitis A
下载PDF
导出
摘要 目的 分析研究盐城市接种甲肝疫苗建立群体免疫屏障控制甲肝流行的效益。方法 对甲肝易感人群进行逐步免疫覆盖 ,观察人群免疫水平变化 ,参照WHO推荐的“国民收入法”评价指标。结果  1993 -2 0 0 0年 ,全市甲肝疫苗累计接种率为 3 4 15 % ,2 0 0 0年抗HAVIgG阳性率为 83 68%。 1994-2 0 0 0年因接种甲肝疫苗而减少甲肝患者 5 5 743例 ,产生的总效益为 3 45× 10 8元 ,净效益为 1 75× 10 8元 ,成本效益比为 1∶6 78。结论 大面积推广接种甲肝疫苗 ,建立有效免疫屏障 ,达到控制甲肝周期性流行的效果 ,不但产生了显著的社会效益 ,而且也产生了巨大的经济效益 ,是一项低投入、高产出的防治对策。 Objective To analyze the economic benefit in Building the Colony Immune Eefence by a Mass Vaccination of Hepatitis A in Yancheng Methods The changes of crowd immune level was observed after carrying out hepatitis A vaccmation by step among the susceptible crowd year by year referring to the evaluation index of nation-income-method recommended by WHO Results The accumulative inoculation rate of hepatitis A Vaccine was 34 15% from 1993 to 2000 The crowd positive rate of anti-HAVIgG was 83 68% in 2000 A total of 55 743 hepatitis A cases had been reduced expectantly after carrying out hepatitis A vaccination from 1993 to 2000 in Yancheng city ,the gained economic benefit was $3 45×10 8 by reducing incidence and the net benefit was $1 75×10 8 as well as the cost-benefit ratio was 1:6 78 Conclusion The results showed that the crowd positive rate of anti-HAVIgG has increased to 85% or so,the colony immune defence of hepatitis A has effectively been built and the periodic epidemics of Hepatitis A has been broken They proved not only that the social benefit was great,but also that the economic benefit was marked The preventive measures are quite effective with low cost
出处 《预防医学情报杂志》 CAS 2002年第5期388-389,共2页 Journal of Preventive Medicine Information
基金 江苏省卫生厅招标课题 (990 1 1 )
关键词 甲型肝炎 甲肝疫苗 群体免疫障碍 成本效益比 Hepatitis A Hepatitis A vaccine Colony immune defence cost benefit ratio
  • 相关文献

参考文献5

二级参考文献16

  • 1顾见青.宝山区甲肝疫苗免疫接种成本-效益分析[J].上海预防医学,2000,12(3):114-115. 被引量:3
  • 2陈胤忠.盐城市90年代甲型肝炎流行态势分析及防制对策研究[J].中华流行病学杂志,1997,18(1).
  • 3郝连杰.肝炎及其后果(第4版)[M].北京:人民卫生出版社,1997.28-29.
  • 4徐志一,中华预防医学杂志,1996年,30卷,增刊,3页
  • 5江世平,中华流行病学杂志,1995年,16卷,140页
  • 6张勇,中国公共卫生学报,1994年,13卷,341页
  • 7Mao S,J Infect Dis,1989年,159卷,621页
  • 8胡孟东,上海医学,1988年,11卷,653页
  • 9朱荣 曹文英 严旭玲 等.江苏省1888—1989年病毒性肝炎流行病学分析[J].江苏卫生防疫,1990,11(2):1-1.
  • 10徐志一,李荣成,孟宗达,张勇,阎纯楷,周廷魁,汪萱怡,龚健,李艳萍,江世平,黄全诚,赵玉良,马景臣,史同深,刘新立,夏建玲,李燕婷,刘洪斌,欧阳佩英.甲型肝炎减毒活疫苗免疫原性和保护效果的初步观察[J].中华医学杂志,1998,78(4):254-256. 被引量:59

共引文献72

同被引文献25

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部